Cargando…

Simultaneous micro measurement of steroid receptors in breast cancer.

The oestradiol (RE) and progesterone (RP) receptor levels were analyzed in 26 tumour fragments (200-500 mg) from breast cancer patients. After pulverization of tissue, one part was analyzed by the routine dextran-coated charcoal (DCC) method and the other by a micromethod as follows: (i) cytosol inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milano, G., Moll, J. L., Formento, J. L., Francoual, M., Krebs, B. P., Namer, M., Boublil, J. L., Lalanne, C. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011502/ https://www.ncbi.nlm.nih.gov/pubmed/6626456

Ejemplares similares

Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.
por: Milano, G., et al.
Publicado: (1987)

Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients
por: Ferrero, J M, et al.
Publicado: (2000)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
por: Etienne, M C, et al.
Publicado: (1999)

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil
por: Magné, N, et al.
Publicado: (2003)

Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.
por: Boublil, J. L., et al.
Publicado: (1985)

Tamoxifen metabolism: pharmacokinetic and in vitro study.
por: Etienne, M. C., et al.
Publicado: (1989)

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors
por: Fischel, J-L, et al.
Publicado: (2005)

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity
por: Etienne, M-C, et al.
Publicado: (2004)

Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.
por: Bernard, S., et al.
Publicado: (1991)

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)
por: Magné, N, et al.
Publicado: (2002)

Value of CA 15:3 in the follow-up of breast cancer patients.
por: Pons-Anicet, D. M., et al.
Publicado: (1987)

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
por: Miller, W R, et al.
Publicado: (2006)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
por: Fischel, J-L, et al.
Publicado: (2001)

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
por: Fischel, J L, et al.
Publicado: (2002)

Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer
por: Magné, N, et al.
Publicado: (2002)

Effects of endocrine therapy on steroid-receptor content of breast cancer.
por: Taylor, R. E., et al.
Publicado: (1982)

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126
por: Bozec, A, et al.
Publicado: (2006)

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
por: Etienne, M. C., et al.
Publicado: (1991)

Simultaneous extraction and detection of peptides, steroids, and proteins in small tissue samples
por: Lu, Chunyu, et al.
Publicado: (2023)

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.
por: Horsfall, D. J., et al.
Publicado: (1986)

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.
por: Kamby, C., et al.
Publicado: (1988)

Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
por: Helin, H., et al.
Publicado: (1990)

The Double-Edged Sword: Are Endocannabinoids Doing More Harm than Good in Epilepsy?
por: Boublil, Brittney L., et al.
Publicado: (2021)

Healing the Lifeworld: On personal and collective individuation
por: Boublil, Elodie
Publicado: (2022)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.
por: Iqbal, M. J., et al.
Publicado: (1983)

Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors
por: Calvillo-Robledo, Argelia, et al.
Publicado: (2021)

Genome-wide crosstalk between steroid receptors in breast and prostate cancers
por: Paakinaho, Ville, et al.
Publicado: (2021)

A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
por: Launay, M. C., et al.
Publicado: (1989)

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
por: Severson, Tesa M., et al.
Publicado: (2018)

Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
por: Battersby, S., et al.
Publicado: (1992)

Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts
por: Bozec, A, et al.
Publicado: (2007)

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
por: Pichon, M. F., et al.
Publicado: (1996)

PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
por: Gion, M., et al.
Publicado: (1993)

Targeting the Androgen Receptor with Steroid Conjugates: Miniperspective
por: Levine, Paul M., et al.
Publicado: (2014)

Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells
por: Verma, Suman, et al.
Publicado: (2009)

Mechanosensory Hairs and Hair-like Structures in the Animal Kingdom: Specializations and Shared Functions Serve to Inspire Technology Applications
por: Boublil, Brittney L., et al.
Publicado: (2021)

The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
por: Villanueva, Hugo, et al.
Publicado: (2018)

Linking Physical Activity to Breast Cancer via Sex Steroid Hormones, Part 2: The Effect of Sex Steroid Hormones on Breast Cancer Risk
por: Drummond, Ann E., et al.
Publicado: (2022)

Sex steroids receptors, hypertension, and vascular ageing
por: Connelly, Paul J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bma351maqfmptkm7qki82mbmon